Site Members can sign up for company wide alerts
Investigation Overview
August 30, 2013 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Hi-Tech Pharmacal Co. (NASDAQ:HITK) shares, was announced concerning whether the takeover of Hi-Tech Pharmacal Co. by Akorn, Inc.for $43.50 per NASDAQ:HITK share is unfair to Hi-Tech Pharmacal stockholders. The investigation by a law firm concerns whether certain officers ...
You must register (for free) or login to view the entire investigation.